Results 131 to 140 of about 10,623 (172)

Balloon pulmonary angioplasty for proximal chronic thromboembolic pulmonary hypertension in patients ineligible for pulmonary endarterectomy. [PDF]

Pulm Circ
Issard J, Fadel E, Dolidon S, Gerardin B, Fabre D, Mitilian D, Mercier O, Jevnikar M, Jais X, Humbert M, Brenot P.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Management of Complications of Balloon Pulmonary Angioplasty

Interventional Cardiology Clinics, 2023
Since the publication of the first case series reporting the outcomes of patients with chronic thromboembolic pulmonary hypertension who underwent treatment with balloon pulmonary angioplasty more than 30 years ago, significant improvements to the procedural technique have made balloon pulmonary angioplasty (BPA) a safe and effective therapy that we ...
Amine, Nasri, Riyaz, Bashir, Vladimir, Lakhter   +2 more
openaire   +3 more sources

Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension

Cardiovascular Intervention and Therapeutics, 2021
Chronic thromboembolic pulmonary hypertension (CTEPH) is caused by chronic stenosis or obstruction of the pulmonary arteries due to thromboembolism. Although previous studies have shown untreated CTEPH has a poor prognosis, the establishment of gold-standard therapies including pulmonary endarterectomy, balloon pulmonary angioplasty (BPA), and medical ...
Kyoko, Hirakawa, Eiichiro, Yamamoto, Seiji, Takashio, Shinsuke, Hanatani, Satoshi, Araki, Satoru, Suzuki, Koichi, Kaikita, Kenichi, Matsushita, Takeshi, Ogo, Kenichi, Tsujita   +9 more
openaire   +2 more sources

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension

CardioVascular and Interventional Radiology, 2018
Chronic thromboembolic pulmonary hypertension (CTEPH) is a potentially lethal outcome of pulmonary embolism. Balloon pulmonary angioplasty (BPA) is aimed at improving pulmonary perfusion and pulmonary hemodynamics and has gained a lot of interest recently in patients either unsuitable for or refractory to surgical pulmonary endarterectomy. This article
J M, Moriarty, S N, Khan, S D, Kao, R, Saggar   +3 more
  +7 more sources

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension

Journal of Vascular and Interventional Radiology, 2019
Chronic thromboembolic pulmonary hypertension (CTEPH) is classified as Group-4 pulmonary hypertension caused by organized thrombi in pulmonary arteries. Pulmonary endarterectomy (PEA) has been shown to improve the symptoms and prognoses of patients with proximal CTEPH.
Sreeja, Sanampudi, Sonja, Bartolome, Sanjeeva, Kalva   +2 more
openaire   +4 more sources

Balloon Pulmonary Angioplasty in the Management of Chronic Thromboembolic Pulmonary Hypertension

RadioGraphics, 2022
Chronic thromboembolic pulmonary hypertension (CTEPH), which is classified as group 4 pulmonary hypertension (PH) in the 2015 European Society of Cardiology/European Respiratory Society guidelines for the diagnosis and treatment of PH, is regarded as a complication of pulmonary embolism and is caused by the transformation of incompletely resolved ...
Satoshi Higuchi, Hiroki Horinouchi, Tatsuo Aoki, Tatsuya Nishii, Yasutoshi Ota, Jin Ueda, Akihiro Tsuji, Hideki Ota, Takeshi Ogo, Tetsuya Fukuda   +9 more
openaire   +2 more sources

Balloon pulmonary angioplasty in inoperable chronic thromboembolic pulmonary hypertension

BMJ Case Reports, 2022
Balloon pulmonary angioplasty (BPA) is an emerging treatment for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or residual/recurrent pulmonary hypertension after pulmonary thromboendarterectomy. We report two patients with inoperable and severe CTEPH who were submitted to the BPA programme after optimised treatment with long-term ...
Pereira, Ana Rita, Calé, Rita, Ferreira, Filipa, Pereira, Helder   +3 more
openaire   +3 more sources

Balloon Pulmonary Angioplasty in Patients With Thromboembolic Pulmonary Hypertension

Current Treatment Options in Cardiovascular Medicine, 2018
Chronic thromboembolic pulmonary hypertension (CTEPH) is the only potentially curable form of precapillary pulmonary hypertension. Although pulmonary endarterectomy (PEA) is the preferred management strategy, a significant number of CTEPH patients will have an inoperable disease.
Panagiotis, Karyofyllis, Varvara, Papadopoulou, Vassilis, Voudris, Hiromi, Matsubara   +3 more
openaire   +2 more sources

Balloon Pulmonary Angioplasty

2017
Balloon pulmonary angioplasty (BPA) is a promising treatment option for patients with chronic thromboembolic pulmonary hypertension who are considered ineligible for surgical treatment. Since 2012, the effect of balloon pulmonary angioplasty has been reported mainly in Japan, but currently, it is attracting the attention of many pulmonary hypertension ...
Hiromi Matsubara, Aiko Ogawa
openaire   +1 more source